Apparent and Internal Validity of a Monte Carlo–Markov Model for Cardiovascular Disease in a Cohort Follow-up Study
Authors:
- Jacqueline C.M. WittemanJWJacqueline C.M. Witteman
- 1 March 2006
- journal article
- research article
- Published by SAGE Publications in Medical Decision Making
- Vol. 26 (2) , 134-144
Abstract
Objective. To determine the apparent and internal validity of the Rotterdam Ischemic heart disease & Stroke Computer (RISC) model, a Monte Carlo–Markov model, designed to evaluate the impact of cardiovascular disease (CVD) risk factors and their modification on life expectancy (LE) and cardiovascular disease–free LE (DFLE) in a general population (hereinafter, these will be referred to together as (DF)LE). Methods. The model is based on data from the Rotterdam Study, a cohort follow-up study of 6871 subjects aged 55 years and older who visited the research center for risk factor assessment at baseline (1990–1993) and completed a follow-up visit 7 years later (original cohort). The transition probabilities and risk factor trends used in the RISC model were based on data from 3501 subjects (the study cohort). To validate the RISC model, the number of simulated CVD events during 7 years’ follow-up were compared with the observed number of events in the study cohort and the original cohort, respectively, and simulated (DF)LEs were compared with the (DF)LEs calculated from multistate life tables. Results .Both in the study cohort and in the original cohort, the simulated distribution of CVD events was consistent with the observed number of events (CVD deaths: 7.1% v. 6.6% and 7.4% v. 7.6%, respectively; non-CVD deaths: 11.2% v. 11.5% and 12.9% v. 13.0%, respectively). The distribution of (DF)LEs estimated with the RISC model consistently encompassed the (DF)LEs calculated with multistate life tables. Conclusions. The simulated events and (DF)LE estimates from the RISC model are consistent with observed data from a cohort follow-up studyKeywords
This publication has 18 references indexed in Scilit:
- Assessing the Sensitivity of Decision-Analytic Results to Unobserved Markers of Risk: Defining the Effects of Heterogeneity BiasMedical Decision Making, 2002
- Internal validation of predictive modelsJournal of Clinical Epidemiology, 2001
- Preventing fatal diseases increases healthcare costs: cause elimination life table approachBMJ, 1998
- Blood Pressure as a Cardiovascular Risk FactorJAMA, 1996
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Determinants of disease and disability in the elderly: The Rotterdam elderly studyEuropean Journal of Epidemiology, 1991
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.American Journal of Public Health, 1987
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985